These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 28754019)
1. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8 Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019 [TBL] [Abstract][Full Text] [Related]
2. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8. Li F; Zhang X; Gordon JR Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749 [TBL] [Abstract][Full Text] [Related]
3. A new protocol for high-yield purification of recombinant human CXCL8((3-72))K11R/G31P expressed in Escherichia coli. Cheng HT; Huang KC; Yu HY; Gao KJ; Zhao X; Li F; Town J; Gordon JR; Cheng JW Protein Expr Purif; 2008 Sep; 61(1):65-72. PubMed ID: 18541440 [TBL] [Abstract][Full Text] [Related]
4. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology. Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682 [TBL] [Abstract][Full Text] [Related]
5. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals. Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619 [TBL] [Abstract][Full Text] [Related]
6. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219 [TBL] [Abstract][Full Text] [Related]
7. CXCL8((3-73))K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo. Li F; Zhang X; Mizzi C; Gordon JR Vet Immunol Immunopathol; 2002 Nov; 90(1-2):65-77. PubMed ID: 12406656 [TBL] [Abstract][Full Text] [Related]
8. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179 [TBL] [Abstract][Full Text] [Related]
9. The antagonist of CXCR1 and CXCR2 protects Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846 [TBL] [Abstract][Full Text] [Related]
10. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors. Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874 [TBL] [Abstract][Full Text] [Related]
11. CXCR1/CXCR2 antagonist G31P inhibits nephritis in a mouse model of uric acid nephropathy. Ye Y; Zhang Y; Wang B; Walana W; Wei J; Gordon JR; Li F Biomed Pharmacother; 2018 Nov; 107():1142-1150. PubMed ID: 30257327 [TBL] [Abstract][Full Text] [Related]
12. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists. Navarro J Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064 [TBL] [Abstract][Full Text] [Related]
13. Il-8((3-73))K11R is a high affinity agonist of the neutrophil CXCR1 and CXCR2. Li F; Gordon JR Biochem Biophys Res Commun; 2001 Aug; 286(3):595-600. PubMed ID: 11511101 [TBL] [Abstract][Full Text] [Related]
14. Porcine CXCR1/2 antagonist CXCL8 Wang X; Li Y; Li L; Jiao Z; Liu X; Cheng G; Gu C; Hu X; Zhang W Sci Rep; 2020 Jan; 10(1):1210. PubMed ID: 31988368 [TBL] [Abstract][Full Text] [Related]
15. CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks lung inflammation in swine barn dust-instilled mice. Schneberger D; Gordon JR; DeVasure JM; Boten JA; Heires AJ; Romberger DJ; Wyatt TA Pulm Pharmacol Ther; 2015 Apr; 31():55-62. PubMed ID: 25681618 [TBL] [Abstract][Full Text] [Related]
16. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598 [TBL] [Abstract][Full Text] [Related]
17. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice. Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013 [TBL] [Abstract][Full Text] [Related]
18. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085 [TBL] [Abstract][Full Text] [Related]
19. IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1/2-AP-1 pathways in THP-1 monocytes. Walana W; Wang JJ; Yabasin IB; Ntim M; Kampo S; Al-Azab M; Elkhider A; Dogkotenge Kuugbee E; Cheng JW; Gordon JR; Li F Hum Immunol; 2018 Nov; 79(11):809-816. PubMed ID: 30125599 [TBL] [Abstract][Full Text] [Related]
20. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2. Zaslaver A; Feniger-Barish R; Ben-Baruch A J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]